Anzeige
Mehr »
Login
Freitag, 18.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
5 Millionen Unzen und steigend: NexGold Mining's unerschlossene Goldstraße
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 883563 | ISIN: US7766961061 | Ticker-Symbol: ROP
Tradegate
17.10.24
14:31 Uhr
520,40 Euro
-0,40
-0,08 %
1-Jahres-Chart
ROPER TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
ROPER TECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
516,40524,8017.10.
519,60521,8017.10.
GlobeNewswire (Europe)
113 Leser
Artikel bewerten:
(0)

Roper Technologies, Inc.: Roper Technologies announces second quarter financial results

SARASOTA, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) reported financial results for the second quarter ended June 30, 2024. The results in this press release are presented on a continuing operations basis.

Second quarter 2024 highlights

  • Revenue increased 12% to $1.72 billion; organic revenue increased 4%
  • GAAP DEPS decreased 7% to $3.12; adjusted DEPS increased 9% to $4.48
  • GAAP net earnings decreased 7% to $337 million; adjusted net earnings increased 9% to $483 million
  • Adjusted EBITDA increased 13% to $695 million
  • Operating cash flow increased 20% to $384 million

"Our portfolio of market-leading technology businesses delivered a solid quarter, highlighted by 12% revenue growth, 13% EBITDA growth, and 24% free cash flow growth," said Neil Hunn, Roper Technologies' President and CEO. "Importantly, our second quarter free cash flow of $367 million brings our trailing-twelve-month adjusted free cash flow to $2.1 billion, representing 32% of revenue."

"During the quarter, we saw improving demand for our enterprise software partially offset by production timing at Neptune. Given these factors, we are increasing the low end of our full year guidance. Additionally, we remain well positioned to execute our disciplined and process-driven capital deployment strategy, with a robust pipeline of attractive acquisition opportunities and substantial M&A capacity," concluded Mr. Hunn.

Updating 2024 guidance

Roper now expects full year 2024 adjusted DEPS of $18.10 - $18.25, compared to previous guidance of $18.05 - $18.25. The Company continues to expect full year total revenue growth of approximately 12% and organic revenue growth of approximately 6%.

For the third quarter of 2024, the Company expects adjusted DEPS of $4.50 - $4.54.

The Company's guidance excludes the impact of unannounced future acquisitions or divestitures.

Conference call to be held at 8:00 AM (ET) today

A conference call to discuss these results has been scheduled for 8:00 AM ET on Wednesday, July 24, 2024. The call can be accessed via webcast or by dialing +1 800-836-8184 (US/Canada) or +1 646-357-8785, using conference call ID 31548. Webcast information and conference call materials will be made available in the Investors section of Roper's website (www.ropertech.com) prior to the start of the call. The webcast can also be accessed directly by using the following URL https://event.webcast. Telephonic replays will be available for up to two weeks and can be accessed by dialing +1 646-517-4150 with access code 31548#.

Use of non-GAAP financial information

The Company supplements its consolidated financial statements presented on a GAAP basis with certain non-GAAP financial information to provide investors with greater insight, increase transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making. Reconciliation of non-GAAP measures to their most directly comparable GAAP measures are included in the accompanying financial schedules or tables. The non-GAAP financial measures disclosed by the Company should not be considered a substitute for, or superior to, financial measures prepared in accordance with GAAP, and the financial results prepared in accordance with GAAP and reconciliations from these results should be carefully evaluated.

Minority interests

Following the sale of a majority stake in its industrial businesses to CD&R, Roper holds a minority interest in Indicor. The fair value of Roper's equity investment in Indicor is updated on a quarterly basis and reported as "equity investments (gain) loss, net." Roper also holds a minority interest in Certinia, a leading provider of professional services automation software. The Company's investment is accounted for under the equity method and its proportionate share of earnings or loss associated with this investment is reported as "equity investments (gain) loss, net." Roper makes non-GAAP adjustments for the impacts associated with these investments.

Table 1: Revenue and adjusted EBITDA reconciliation ($M)
(from continuing operations)
Q2 2023 Q2 2024 V %
GAAP revenue$1,531 $1,717 12%
Components of revenue growth
Organic 4%
Acquisitions 8%
Foreign exchange -%
Revenue growth 12%
Adjusted EBITDA reconciliation
GAAP net earnings$361 $337
Taxes 103 88
Interest expense 35 68
Depreciation 9 9
Amortization 176 192
EBITDA$683 $694 2%
Financial impacts associated with the minority
investments in Indicor & Certinia A
(66) 1
Adjusted EBITDA$617 $695 13%
% of revenue 40.3% 40.5% +20 bps
Table 2: Adjusted net earnings reconciliation ($M)
(from continuing operations)
Q2 2023 Q2 2024 V %
GAAP net earnings$361 $337 (7)%
Financial impacts associated with the minority
investments in Indicor & Certinia A
(53) -
Amortization of acquisition-related intangible
assets B
135 146
Adjusted net earnings$442 $483 9%
Table 3: Adjusted DEPS reconciliation
(from continuing operations)
Q2 2023 Q2 2024 V %
GAAP DEPS$3.36 $3.12 (7)%
Financial impacts associated with the minority
investments in Indicor & Certinia A
(0.50) -
Amortization of acquisition-related intangible
assets B
1.25 1.35
Adjusted DEPS$4.12 $4.48 9%
Table 4: Adjusted cash flow reconciliation ($M)
(from continuing operations)
Q2 2023 Q2 2024 V % TTM 2024
Operating cash flow$320 $384 20% $2,168
Taxes paid in period related to
divestiture
- - 32
Adjusted operating cash flow$320 $384 20% $2,200
Capital expenditures (15) (7) (59)
Capitalized software expenditures (9) (11) (41)
Adjusted free cash flow$295 $367 24% $2,100
Table 5: Forecasted adjusted DEPS reconciliation
(from continuing operations)
Q3 2024 FY 2024
Low end High end Low end High end
GAAP DEPS C$3.16 $3.20 $12.76 $12.91
Transaction-related expenses for
completed acquisitions
- - 0.01 0.01
Financial impacts associated with the
minority investments in Indicor & Certinia A
TBD TBD TBD TBD
Amortization of acquisition-related
intangible assets B
1.34 1.34 5.33 5.33
Adjusted DEPS$4.50 $4.54 $18.10 $18.25

Footnotes:

A.Adjustments related to the financial impacts associated with the minority investments in Indicor & Certinia as shown below ($M, except per share data). Forecasted results do not include any potential impacts associated with our minority investments in Indicor or Certinia, as these potential impacts cannot be reasonably predicted. These impacts will be excluded from all non-GAAP results in future periods.
Q2 2023A Q2 2024A Q3 2024E FY 2024E
Pretax$ (66) $ 1 TBD TBD
After-tax$ (53) $ - TBD TBD
Per share$ (0.50) $ - TBD TBD
B.Actual results and forecast of estimated amortization of acquisition-related intangible assets as shown below ($M, except per share data). These adjustments are taxed at 21%.
Q2 2023A Q2 2024A Q3 2024E FY 2024E
Pretax$ 170 $ 185 $ 184 $ 729
After-tax$ 135 $ 146 $ 145 $ 576
Per share$ 1.25 $ 1.35 $ 1.34 $ 5.33
C.Forecasted GAAP DEPS do not include any potential impacts associated with our minority investments in Indicor or Certinia. These impacts will be excluded from all non-GAAP results in future periods.

Note: Numbers may not foot due to rounding.

About Roper Technologies

Roper Technologies is a constituent of the Nasdaq 100, S&P 500, and Fortune 1000. Roper has a proven, long-term track record of compounding cash flow and shareholder value. The Company operates market leading businesses that design and develop vertical software and technology enabled products for a variety of defensible niche markets. Roper utilizes a disciplined, analytical, and process-driven approach to redeploy its excess capital toward high-quality acquisitions. Additional information about Roper is available on the Company's website at www.ropertech.com.

Contact information:
Investor Relations
941-556-2601
investor-relations@ropertech.com

The information provided in this press release contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements may include, among others, statements regarding operating results, the success of our internal operating plans, and the prospects for newly acquired businesses to be integrated and contribute to future growth, profit and cash flow expectations. Forward-looking statements may be indicated by words or phrases such as "anticipate," "estimate," "plans," "expects," "projects," "should," "will," "believes," "intends" and similar words and phrases. These statements reflect management's current beliefs and are not guarantees of future performance. They involve risks and uncertainties that could cause actual results to differ materially from those contained in any forward-looking statement. Such risks and uncertainties include our ability to identify and complete acquisitions consistent with our business strategies, integrate acquisitions that have been completed, realize expected benefits and synergies from, and manage other risks associated with, acquired businesses, including obtaining any required regulatory approvals with respect thereto. We also face other general risks, including our ability to realize cost savings from our operating initiatives, general economic conditions and the conditions of the specific markets in which we operate, including risks related to labor shortages and rising interest rates, changes in foreign exchange rates, difficulties associated with exports, risks associated with our international operations, cybersecurity and data privacy risks, including litigation resulting therefrom, risks related to political instability, armed hostilities, incidents of terrorism, public health crises (such as the COVID-19 pandemic) or natural disasters, increased product liability and insurance costs, increased warranty exposure, future competition, changes in the supply of, or price for, parts and components, including as a result of the current inflationary environment and ongoing supply chain constraints, environmental compliance costs and liabilities, risks and cost associated with litigation, potential write-offs of our substantial intangible assets, and risks associated with obtaining governmental approvals and maintaining regulatory compliance for new and existing products. Important risks may be discussed in current and subsequent filings with the SEC. You should not place undue reliance on any forward-looking statements. These statements speak only as of the date they are made, and we undertake no obligation to update publicly any of them in light of new information or future events.

Roper Technologies, Inc.
Condensed Consolidated Balance Sheets (unaudited)
(Amounts in millions)
June 30, 2024 December 31, 2023
ASSETS:
Cash and cash equivalents$251.5 $214.3
Accounts receivable, net 739.9 829.9
Inventories, net 128.8 118.6
Income taxes receivable 48.0 47.7
Unbilled receivables 123.8 106.4
Other current assets 198.2 164.5
Total current assets 1,490.2 1,481.4
Property, plant and equipment, net 116.4 119.6
Goodwill 18,313.1 17,118.8
Other intangible assets, net 8,645.3 8,212.1
Deferred taxes 30.7 32.2
Equity investments 842.8 795.7
Other assets 409.0 407.7
Total assets$29,847.5 $28,167.5
LIABILITIES AND STOCKHOLDERS' EQUITY:
Accounts payable$149.4 $143.0
Accrued compensation 189.5 250.0
Deferred revenue 1,468.3 1,583.8
Other accrued liabilities 469.7 446.5
Income taxes payable 30.9 40.4
Current portion of long-term debt, net 500.0 499.5
Total current liabilities 2,807.8 2,963.2
Long-term debt, net of current portion 6,923.9 5,830.6
Deferred taxes 1,585.4 1,513.1
Other liabilities 391.4 415.8
Total liabilities 11,708.5 10,722.7
Common stock 1.1 1.1
Additional paid-in capital 2,923.0 2,767.0
Retained earnings 15,374.3 14,816.3
Accumulated other comprehensive loss (142.8) (122.8)
Treasury stock (16.6) (16.8)
Total stockholders' equity 18,139.0 17,444.8
Total liabilities and stockholders' equity$29,847.5 $28,167.5
Roper Technologies, Inc.
Condensed Consolidated Statements of Earnings (unaudited)
(Amounts in millions, except per share data)
Three months ended
June 30,
Six months ended
June 30,
2024 2023 2024 2023
Net revenues$1,716.8 $1,531.2 $3,397.5 $3,000.9
Cost of sales 523.5 464.1 1,023.2 915.2
Gross profit 1,193.3 1,067.1 2,374.3 2,085.7
Selling, general and administrative expenses 699.1 631.8 1,398.8 1,249.4
Income from operations 494.2 435.3 975.5 836.3
Interest expense, net 67.5 34.8 120.7 72.2
Equity investments (gain) loss, net 0.8 (66.0) (56.2) (64.8)
Other expense, net 0.6 2.8 1.8 5.1
Earnings before income taxes 425.3 463.7 909.2 823.8
Income taxes 88.2 102.7 190.1 178.5
Net earnings from continuing operations 337.1 361.0 719.1 645.3
Loss from discontinued operations, net of tax - - - (1.2)
Gain on disposition of discontinued operations,
net of tax
- 3.9 - 3.9
Net earnings from discontinued operations - 3.9 - 2.7
Net earnings$337.1 $364.9 $719.1 $648.0
Net earnings per share from continuing
operations:
Basic$3.15 $3.38 $6.72 $6.06
Diluted$3.12 $3.36 $6.66 $6.02
Net earnings per share from discontinued
operations:
Basic$- $0.04 $- $0.03
Diluted$- $0.04 $- $0.02
Net earnings per share:
Basic$3.15 $3.42 $6.72 $6.09
Diluted$3.12 $3.40 $6.66 $6.04
Weighted average common shares outstanding:
Basic 107.1 106.6 107.0 106.4
Diluted 107.9 107.4 107.9 107.2
Roper Technologies, Inc.
Selected Segment Financial Data (unaudited)
(Amounts in millions; percentages of net revenues)
Three months ended June 30, Six months ended June 30,
2024 2023 2024 2023
Amount % Amount % Amount % Amount %
Net revenues:
Application Software$931.8 $770.3 $1,827.0 $1,531.7
Network Software 364.2 358.1 735.0 712.6
Technology Enabled
Products
420.8 402.8 835.5 756.6
Total$1,716.8 $1,531.2 $3,397.5 $3,000.9
Gross profit:
Application Software$641.1 68.8% $531.0 68.9% $1,266.8 69.3% $1,051.5 68.6%
Network Software 307.8 84.5% 303.9 84.9% 624.1 84.9% 603.3 84.7%
Technology Enabled
Products
244.4 58.1% 232.2 57.6% 483.4 57.9% 430.9 57.0%
Total$1,193.3 69.5% $1,067.1 69.7% $2,374.3 69.9% $2,085.7 69.5%
Operating profit*:
Application Software$251.1 26.9% $201.2 26.1% $490.7 26.9% $394.4 25.7%
Network Software 159.1 43.7% 153.1 42.8% 326.1 44.4% 300.6 42.2%
Technology Enabled
Products
146.7 34.9% 139.1 34.5% 282.9 33.9% 254.6 33.7%
Total$556.9 32.4% $493.4 32.2% $1,099.7 32.4% $949.6 31.6%
* Segment operating profit is before unallocated corporate general and administrative expenses and enterprise-wide stock-based compensation. These expenses were $62.7 and $58.1 for the three months ended June 30, 2024 and 2023, respectively, and $124.2 and $113.3 for the six months ended June 30, 2024 and 2023, respectively.
Roper Technologies, Inc.
Condensed Consolidated Statements of Cash Flows (unaudited)
(Amounts in millions)
Six months ended
June 30,
2024 2023
Cash flows from operating activities:
Net earnings from continuing operations$719.1 $645.3
Adjustments to reconcile net earnings from continuing operations to cash
flows from operating activities:
Depreciation and amortization of property, plant and equipment 18.5 17.3
Amortization of intangible assets 377.2 350.6
Amortization of deferred financing costs 4.5 5.1
Non-cash stock compensation 73.3 63.5
Equity investments gain, net (56.2) (64.8)
Income tax provision 190.1 178.5
Changes in operating assets and liabilities, net of acquired businesses:
Accounts receivable 96.7 46.7
Unbilled receivables (17.7) (14.9)
Inventories (11.0) (5.9)
Accounts payable 4.5 17.9
Other accrued liabilities (47.3) (91.0)
Deferred revenue (122.6) (98.3)
Cash income taxes paid (284.3) (231.5)
Other, net (29.2) (33.5)
Cash provided by operating activities from continuing operations 915.6 785.0
Cash used in operating activities from discontinued operations - (1.7)
Cash provided by operating activities 915.6 783.3
Cash flows from (used in) investing activities:
Acquisitions of businesses, net of cash acquired (1,858.3) (17.3)
Capital expenditures (15.9) (24.9)
Capitalized software expenditures (20.5) (19.3)
Distributions from equity investment 8.4 12.1
Other, net (1.1) (2.9)
Cash used in investing activities from continuing operations (1,887.4) (52.3)
Cash provided by disposition of discontinued operations - 2.0
Cash used in investing activities (1,887.4) (50.3)
Cash flows from (used in) financing activities:
Borrowings under revolving line of credit, net 1,090.0 -
Cash dividends to stockholders (160.6) (144.8)
Proceeds from stock-based compensation, net 75.9 60.8
Treasury stock sales 10.3 8.4
Other (0.2) (0.2)
Cash provided by (used in) financing activities 1,015.4 (75.8)
Effect of exchange rate changes on cash (6.4) 12.8
Net increase in cash and cash equivalents 37.2 670.0
Cash and cash equivalents, beginning of period 214.3 792.8
Cash and cash equivalents, end of period$251.5 $1,462.8

© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.